View in EDS PDF Full Text

3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: 3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma.
Authors: Chim, Chor Sang1 (AUTHOR) jcschim@hku.hk, Kumar, Shaji2 (AUTHOR), Wong, Vincent Kai Chung3 (AUTHOR), Ngai, Cheong1 (AUTHOR), Kwong, Yok Lam1 (AUTHOR)
Source: Hematology. Dec 2021, Vol. 26 Issue 1, p652-655. 4p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 154319225
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Chim%2C+Chor+Sang%22">Chim, Chor Sang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jcschim@hku.hk</i><br /><searchLink fieldCode="AR" term="%22Kumar%2C+Shaji%22">Kumar, Shaji</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+Vincent+Kai+Chung%22">Wong, Vincent Kai Chung</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ngai%2C+Cheong%22">Ngai, Cheong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kwong%2C+Yok+Lam%22">Kwong, Yok Lam</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Hematology%22">Hematology</searchLink>. Dec 2021, Vol. 26 Issue 1, p652-655. 4p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=154319225
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/16078454.2021.1965737
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 652
    Titles:
      – TitleFull: 3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chim, Chor Sang
      – PersonEntity:
          Name:
            NameFull: Kumar, Shaji
      – PersonEntity:
          Name:
            NameFull: Wong, Vincent Kai Chung
      – PersonEntity:
          Name:
            NameFull: Ngai, Cheong
      – PersonEntity:
          Name:
            NameFull: Kwong, Yok Lam
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec 2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 10245332
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Hematology
              Type: main
ResultId 1